Itraconazole

伊曲康唑

Report date: 2026/05/11 20:01:57
NMEQIDP

Base Information

Drug NameItraconazole
Drug Alias NameItraconazol依他康唑依曲康唑Itraconazolumlow-dose itraconazole +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsEsophageal adenocarcinomaHormone-Resistant Prostate NeoplasmsRosacea +[32] 
Global Approved IndicationsHistoplasmosisBlastomycosisAspergillosis +[4] 
Approved Indications in ChinaMycoses
Original Approved Country/TerritoryN/A
Original Approved Date1988/01/01
Country/TerritoryCanadaPanamaUnited States +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesCombined Military Hospital AbbottabadJanssen Pharmaceuticals IncMansoura University +[9] 
Inactive CompaniesStiefel LaboratoriesHalcygen Pharmaceuticals LtdC.H. Boehringer Sohn Ag & Co. Kg +[16] 
Active IndicationsEsophageal adenocarcinomaBronchiectasisBarrett Esophagus +[14] 
Inactive IndicationsHormone-Resistant Prostate NeoplasmsRosaceaFebrile Neutropenia +[18] 

Other Information

ATC CodeJ02AC02
Related LinksWikipediaDrugBankKEGG